Bioflux® provides real-time active monitoring – 24/7!

Bioflux® is a high-precision, single-unit mobile cardiac telemetry (MCT) device that provides real-time monitoring and transmission of your ambulatory patients’ ECG information. The Bioflux® system is a complete solution for remote cardiac monitoring that merges seamlessly with physicians’ existing platforms and workflows.

We track over 100 billion heartbeats a year, monitored in real-time by our certified cardiac technicians with unmatched reporting capabilities.

How To Videos

01 Bioflux Contents

About bioflux device and its accessories

Clinical portal

You asked and we listened!

The Bioflux® online portal was designed by clinicians for clinicians.

After speaking with our healthcare professionals, we integrated their most desired features.


Intuitive online portal design

Report views organized
by type & priority

Secure on-the-go access,
on your PC, mobile and tablet

Integrated access to all reports

Support for expedited service

Our device features


A 4 in 1 device with an
integrated cellular


Our proprietary, FDA-cleared
software featuring advanced beat
& arrhythmia autodetection for
increased clinical yield


Monitoring & recording
3 channels of remote ECG data
for up to 30 days


Easily programmable auto-triggers
on bradycardia, tachycardia,
asystole, and atrial fibrillation


An integrated patient symptom
diary for manual events


Single-button, integrated
touchscreen, ease of use –
encourages patient adherence

1000 Samples

A monitoring rate of up to 1000
samples per second provides
unparalleled clinical precision


Encrypted data & secure
reporting system to ensure
patient confidentiality


24/7 Call Center
available for all patient
questions or concerns

3 Channel

3 Channel Vectorswap can
remotely switch channels
for a better trace

30 day

Up to 30-day
wear duration


Leveraging cellular IoT

Revolutionary technologies


    Bioflux® Clinic App

    Bioflux® Clinic is a mobile application used by physicians & clinicians monitoring patients with the Bioflux device. The app alerts the user to events, allows them to view & acknowledge reports or contact the Call Center.


    How it works

    Actively monitors & analyzes a patient’s ECG data in real time

    Continuously collects & automatically transmits data to our secure cloud

    Uses state of the art analysis, providing customized reports for each healthcare provider

    Real time reporting improves physician workflow & reduces the time for patient diagnosis

    Bioflux®—answering the need forimproved cardiac monitoring1

    Great progress has been made in the treatment of cardiovascular disease (CVD). And yet, CVD is listed as the underlying cause of the deaths of more than 800,000 people in the US each year. That’s about one death every 40 seconds. That far exceeds the toll of all types of cancer combined. In fact, almost a third of all deaths in the US each year—from all causes—are attributable to CVD.

    An estimated 85.6 million Americans, or 35% of the country’s population, suffer from one or more types of CVD. Contrary to stereotypes, only about half are over the age of 60, and the numbers of men and women are roughly equal.

    US adults with at least one chronic disease

    Fraction of American adults with CVD who are under 60

    Fraction of American adults with CVD who are female

    Making matters worse, the costs imposed by CVD on severely over-burdened healthcare systems are staggering. Annual health expenditures in the US linked to coronary heart disease and congestive heart failure total more than $200 billion per year. The American Heart Association predicts that number will almost double by 2030.

    To maximize the benefits of advances in medical treatment, technology is needed that will help physicians diagnose cardiovascular diseases both precisely and early in their development. Biotricity is answering that call with Bioflux®.

    1. Software FDA cleared, hardware FDA 510(k) cleared [return]

    2. All figures quoted on this page come from Mozaffarian D, et al. (1 November 2016) Heart disease and stroke statistics-2016 update. Circulation, 134(18). [return]